Home > News > Content

POCT Of Laihe, Rated As A Key Intelligence Project

Jun 21, 2018

Hangzhou Municipal Human Resources and the Social Security Bureau announced on 12th Jun the list of Hangzhou “115” Importing Foreign (Overseas) Intelligence Planning Project in the year 2018. The Industrialization of real time point-of-care testing (POCT) Quantitative Immunofluorescence Analysis Platform of Hangzhou Laihe Biotech Co., Ltd. was rated as a Key Intelligence Project.


Hangzhou “115” Importing Foreign (Overseas) Intelligence Planning Project is a national intensified program in order to encourage enterprises and institutions to introduce high-end foreign (overseas) experts who play a leading role in the development of key industries, to promote the strategy of talents market and urban internationalization, to create beautiful Chinese Samples, and finally to achieve the goal of building world-famous city.


Our product the Quantitative Immunofluorescence Analyzer (POCT) is used in the immunofluorescence analysis of human samples, based on immunochromatographic dry reagent. Our The current corollary tests we have are Infection(PCT CRP), Cardiology(hsCRP CTnl NT-proBNP CK-MB MYO), Tumor(PSA AFP CEA) Total IgE, and there are 3 new Combo Tests coming soon:

(1)CTNI+CKMB+MYO

(2)CTNI+D-Dimer+NT-ProBNP

(3)CTNI+CKMB+MYO+D-Dimer+NT-ProBNP



E-mail:office@lyher.com

http://www.lyherbio.com